Julia Lainster

A significant and persistent gap in stroke risk between Black and White adults in the United States has long challenged the medical community, but a newly validated assessment tool offers a promising new direction for closing this divide through personalized, actionable health insights. A

A state-of-the-art biologic drug, meticulously designed to fight a specific disease and carrying a price tag that can exceed several hundred thousand dollars, inexplicably fails in a patient who seemed a perfect candidate for the treatment. This frustrating scenario, long a puzzle for clinicians,

The routine procedure of drawing blood remains one of the most common yet consistently invasive practices in modern medicine, a necessary discomfort for millions seeking crucial health insights. But a new frontier in diagnostics is emerging, one that promises to replace the needle with a simple,

With deep expertise in biopharmaceutical innovation and a sharp focus on oncology, Ivan Kairatov has been at the forefront of translating complex molecular discoveries into potential therapeutic strategies. Today, he joins us to discuss a groundbreaking study that shines a new light on one of

The quiet revolution happening in primary care clinics across the globe is driven by an artificial intelligence that promises to solve systemic pressures but is simultaneously creating a significant, unaddressed patient safety crisis. This paradox lies at the heart of AI's rapid adoption into the

For individuals born with the rare and debilitating genetic disorder Wiskott-Aldrich syndrome, the hope for a cure has long been shadowed by the immense challenge of finding a perfectly matched stem cell donor. This condition, which severely compromises the immune system and blood clotting, leaves

The familiar routine of an annual physical, with its sterile rooms and apprehensive wait for a needle, is quietly becoming a relic of a bygone era in medicine as a profound transformation reshapes the landscape of personal health. A new wave of innovation is dismantling the centralized,

For millions grappling with mysterious health conditions, the answer often lies encrypted within their own DNA, but unlocking it has been a frustrating and prolonged ordeal. This "diagnostic odyssey" can span years, sending patients through a gauntlet of tests and consultations while the root cause

The year 2025 marked a watershed moment in oncology, as the U.S. Food and Drug Administration (FDA) greenlit three groundbreaking therapies that significantly advance the paradigm of precision medicine for patients with breast cancer. These approvals underscore a definitive shift away from

With a rich background in biopharmaceutical research and a keen eye on the intersection of technology and health, Ivan Kairatov has dedicated his career to understanding the molecular underpinnings of chronic disease. His work provides critical insights into how modern lifestyle choices,